Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
In an interview with 60 Minutes, the Federal Trade Commission head said the agency believes it has the authority to ban ...
A Federal Trade Commission (FTC) report found that social and video streaming services pose serious privacy risks, especially ...
A decision on the Federal Trade Commission’s noncompete ban came down to the wire. A federal judge in Texas recently blocked the FTC’s noncompete ban, which was approved by the commission ...
At the Federal Trade Commission, Chair Lina Khan's mission is breaking illegal monopolies, blocking mergers that stifle ...
At this week’s National Advertising Division Annual Conference, FTC Commissioner Melissa Holyoak and FTC Bureau of Consumer Protection Director ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback